Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Siok Ping Yeo
Institution:
Tessa Therapeutic (Singapore)
Observed institutions:
Agency for Science, Technology and Research,
Nanyang Technological University,
Singapore Immunology Network,
Tessa Therapeutic (Singapore)
ORCID:
0009-0001-8652-3579
Observed ORCID:
0009-0001-8652-3579
OpenAlex ID:
A5088771865
Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab
2016
·
Zhenkun Na
, Siok Ping Yeo
, et al.
·
Cell Research
·
153
PDF
Imaging PD-L1 Expression with ImmunoPET
2017
·
Charles Truillet
, Hsueh Ling J. Oh
, et al.
·
Bioconjugate Chemistry
·
134
Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T Cells
2021
·
Wen-Hsin Sandy Lee
, Zhiyong Ye
, et al.
·
Molecular Cancer Therapeutics
·
59
A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy
2014
·
Angeline XH Goh
, Sebastien Bertin-Maghit
, et al.
·
mAbs
·
59
PDF
Silencing of Diphthamide Synthesis 3 (Dph3) Reduces Metastasis of Murine Melanoma
2012
·
Lei Wang
, Yu Shi
, et al.
·
PLoS ONE
·
24
PDF
B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
·
Cancer Research Communications
·
6
Supplementary figure 3 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
FIGURE 5 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
FIGURE 6 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
FIGURE 1 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
Table S1 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
Table S1 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
Supplementary figure 7 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
Supplementary figure 8 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
Supplementary Data from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
Supplementary figure 2 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
FIGURE 7 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
Supplementary figure 1 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
FIGURE 8 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
Supplementary figure 5 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
Supplementary figure 6 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
Supplementary figure 4 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
FIGURE 6 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
FIGURE 4 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
FIGURE 2 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024
·
Siok Ping Yeo
, Lindsay Kua
, et al.
Show more works
View as search
Works count:
39
Citation count:
435
H-index:
6
I10-index:
5
Year
Topic
Type
